Safety Alert: Class II: Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation impurity.
healthClass IIRecalled on Sep 17, 2025
Succinylcholine Chloride Injection, USP 200 mg/10 mL (20 mg/mL), Rx only, 10 mL Multiple-dose Vial, Sterile, Manufactured by Zydus Lifesciences Ltd
🔢 270,125 Vials
Sold At: Zydus Pharmaceuticals (USA) Inc(MS, OH, LA, and Puerto Rico)
Recall #: FDA-DRUG-D-0623-2025
Source: FDA-ENFORCEMENT
Product Identification
- Lot/Batch Codes:
- Lot #s: L400077, exp: 8/31/2025; L400113, exp.: 9/30/2025; L400372, L400373, exp.: 3/31/2026; L400374, exp.: 4/30/2026.
Get AI-Powered Summary
Premium members get instant insights to help you understand recalls faster
Instant 1-3 sentence summary
Quick action bullets
Clear guidance on what to do
Summary
Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation impurity.
What to do next
- 1Stop using this product - may cause temporary or medically reversible health problems
- 2Check with retailer or manufacturer for recall status and remedy options
- 3Contact Zydus Pharmaceuticals (USA) Inc for return or refund information
- 4Visit the official FDA recall page for complete details
Summaries only; always follow the official notice.